|
|
|
Insider
Information: |
Keating Laurie |
Relationship: |
Director |
City: |
Cambridge |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
23,298 |
|
Indirect Shares
|
434 |
|
|
Direct
Value |
$821,545 |
|
|
Indirect Value
|
$64,840 |
|
|
Total
Shares |
23,732 |
|
|
Total
Value |
$886,385 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Alnylam Pharmaceuticals Inc |
ALNY |
EVP, Chief Legal Officer |
2021-08-05 |
5,132 |
2021-08-05 |
434 |
Premium* |
|
Immuneering Corp |
IMRX |
|
2022-05-16 |
14,000 |
2021-08-03 |
0 |
Premium* |
|
Pepgen Inc. |
PEPG |
Director |
2022-05-06 |
4,166 |
2022-05-06 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
52 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 3
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
ALNY |
Alnylam Pharmaceuticals I... |
SVP, GC and Secretary |
|
2017-05-30 |
4 |
B |
$65.35 |
$751,502 |
D/D |
11,500 |
11,500 |
2.74 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
SVP, GC and Secretary |
|
2017-12-01 |
4 |
AS |
$133.37 |
$4,076,823 |
D/D |
(30,000) |
11,500 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
SVP, GC and Secretary |
|
2017-12-01 |
4 |
OE |
$77.40 |
$2,322,000 |
D/D |
30,000 |
41,500 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
SVP, GC & Secretary |
|
2017-12-20 |
4 |
AS |
$120.88 |
$757,398 |
D/D |
(6,249) |
11,500 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
SVP, GC & Secretary |
|
2017-12-20 |
4 |
OE |
$42.22 |
$263,833 |
D/D |
6,249 |
17,749 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
SVP, GC & Secretary |
|
2017-12-29 |
4 |
OE |
$77.40 |
$232,200 |
D/D |
3,000 |
14,500 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
SVP, GC & Secretary |
|
2018-03-12 |
4 |
AS |
$140.00 |
$1,400,000 |
D/D |
(10,000) |
14,500 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
SVP, GC & Secretary |
|
2018-03-12 |
4 |
OE |
$77.40 |
$774,000 |
D/D |
10,000 |
24,500 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
SVP, GC & Secretary |
|
2018-03-13 |
4 |
AS |
$150.00 |
$1,500,000 |
D/D |
(10,000) |
14,500 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
SVP, GC & Secretary |
|
2018-03-13 |
4 |
OE |
$77.40 |
$774,000 |
D/D |
10,000 |
24,500 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
SVP, GC & Secretary |
|
2018-03-20 |
4 |
OE |
$42.22 |
$65,948 |
D/D |
1,562 |
16,062 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
SVP, GC & Secretary |
|
2018-03-20 |
4 |
AS |
$146.36 |
$234,033 |
D/D |
(1,562) |
14,500 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
SVP, GC & Secretary |
|
2018-04-16 |
4 |
A |
$0.00 |
$0 |
I/I |
31 |
288 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
SVP, GC & Secretary |
|
2018-06-20 |
4 |
AS |
$105.04 |
$164,178 |
D/D |
(1,563) |
14,500 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
SVP, GC & Secretary |
|
2018-06-20 |
4 |
OE |
$42.22 |
$65,990 |
D/D |
1,563 |
16,063 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
SVP, GC & Secretary |
|
2018-07-10 |
4 |
A |
$0.00 |
$0 |
I/I |
32 |
320 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
SVP, GC & Secretary |
|
2018-08-13 |
4 |
D |
$90.95 |
$55,025 |
D/D |
(605) |
15,258 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
SVP, GC & Secretary |
|
2018-08-13 |
4 |
A |
$0.00 |
$0 |
D/D |
1,363 |
15,863 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
EVP, Chief Legal Officer |
|
2018-10-18 |
4 |
A |
$0.00 |
$0 |
I/I |
14 |
334 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
EVP, Chief Legal Officer |
|
2019-04-09 |
4 |
A |
$0.00 |
$0 |
I/I |
41 |
375 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
EVP, Chief Legal Officer |
|
2019-07-11 |
4 |
A |
$0.00 |
$0 |
I/I |
49 |
424 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
EVP, Chief Legal Officer |
|
2019-10-10 |
4 |
A |
$0.00 |
$0 |
I/I |
10 |
434 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
EVP, Chief Legal Officer |
|
2020-01-27 |
4/A |
OE |
$77.40 |
$283,516 |
D/D |
3,663 |
12,258 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
EVP, Chief Legal Officer |
|
2020-01-27 |
4 |
AS |
$115.55 |
$4,829,970 |
D/D |
(41,037) |
8,595 |
0 |
% |
|
ALNY |
Alnylam Pharmaceuticals I... |
EVP, Chief Legal Officer |
|
2020-01-27 |
4 |
OE |
$42.22 |
$1,451,270 |
D/D |
34,374 |
49,632 |
0 |
- |
|
52 Records found
|
|
Page 1 of 3 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|